Spanish Health Ministry Seeks Public Opinion on Tobacco Regulations

Regulations by 2FIRSTS.ai
Apr.09.2024
Spanish Health Ministry Seeks Public Opinion on Tobacco Regulations
Spanish Health Ministry seeks public input on Royal Decree draft, aiming to further tobacco regulation following nationwide smoking ban.

According to Spanish media La Voz de Galicia on April 8th, the Spanish Ministry of Health is officially seeking public opinions on a draft royal decree regarding plain packaging and the prohibition of additives in tobacco and related products. The aim is to evaluate and improve this legislative reform proposal. This is the first legislative measure taken following the implementation of the comprehensive smoking ban plan last Friday (April 5th).

 

Health Minister Monica Garcia emphasized at a social health breakfast organized by the European News Agency, "The plain packaging policy is effective, as it not only eliminates the attractiveness of tobacco packaging as advertising, but also helps to inspire people to quit smoking." Currently, many countries such as Australia, France, Norway, and Denmark have fully implemented plain packaging policies and have achieved significant results.

 

From now (April 8th) until April 23rd, all Spanish citizens, organizations and associations are free to express their opinions on this policy. The proposal will reform the Royal Decree 579/2017 that regulates various aspects of tobacco manufacturing, sales and commercialization.

 

The bill argues that "health protection" necessitates "emergency updates" to regulations in order to address issues such as the steady increase in tobacco and related product consumption and the exposure of ordinary people, especially young people, to new forms of nicotine consumption. It claims that current regulations are unable to keep up with the supply of these new products on the market, losing effectiveness in combining health warnings while maintaining product appeal. More importantly, there is a regulatory gap for nicotine-free e-cigarettes and herbal smoking products.

 

Therefore, the legislation aims to introduce many improvements within existing regulations, such as implementing plain packaging and "properly categorizing emerging products" to enhance labeling and packaging.

 

Additionally, this includes banning the use of tobacco-flavored additives in tobacco and related products, as well as additives and ingredients that distort health regulations' objectives or may be more appealing to consumers.

 

This is the first initiative launched by the Spanish Ministry of Health since the release of the Comprehensive Tobacco Addiction Prevention Plan (PIT) for 2024-2027. The plan was approved last Friday (April 5th) by the entire Interregional Health Committee after being reviewed.

 

Minister of Health Monica Garcia stated:

 

I want to express my deep gratitude to all the local regions that are working towards achieving this important consensus. For those like the skeptics in 2005 who predicted the first tobacco act would have a 'doomsday' effect and ultimately failed, as well as those 'lobby groups with commercial interests,' they will hit a wall if they try to influence this department on anything related to protecting the health of our citizens.

 

In addition to other measures, some of the initiatives included in the plan will harmonize regulations on tobacco-related products with traditional tobacco regulations: The Ministry of Finance has revised tobacco taxes to bring Spain closer to its neighboring countries, with hopes that this increase in revenue can be used to advance public health policies. At the same time, it also includes expanding smoke-free zones.

 

Another goal of the program is to promote research on tobacco and its effects, strengthening evidence on the impacts of new tobacco products. The minister criticized those who were against the plan from the start, had apocalyptic ideas, and made similar statements as early as 2005 and 2010.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Inside Nicotine-Pouch M&A Through Imperial's Yoik Deal: Latham, KPMG, PwC, Goldman Sachs and Morgan Stanley Form the Adviser Lineup
Imperial Brands' acquisition of Swedish Helwit owner Yoik Group AB has highlighted the professional-services firms supporting cross-border oral nicotine M&A. Latham & Watkins and KPMG advised Imperial, while PwC and TM & Partners advised Yoik. KPMG also appeared on Imperial's acquisition of Black Buffalo earlier in 2026, while PwC played an extensive role in KT&G's acquisition of Swedish nicotine-pouch company Another Snus Factory. Imperial's public disclosures put the global modern oral nicotine delivery market at approximately £8.8 billion in retail sales and 23.5 billion pouches in 2024
Sep.20
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08